Detalhe da pesquisa
1.
Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infection.
Nat Immunol
; 22(11): 1428-1439, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34471264
2.
Escape of HIV-1 envelope glycoprotein from the restriction of infection by IFITM3.
J Virol
; 95(5)2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33298540
3.
Evolution of the Envelope Glycoprotein of HIV-1 Clade B toward Higher Infectious Properties over the Course of the Epidemic.
J Virol
; 93(6)2019 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30567994
4.
Advances in human monoclonal antibody therapy for HBV infection.
Curr Opin Virol
; 53: 101205, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35123237
5.
Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2.
J Exp Med
; 219(7)2022 07 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35704748
6.
A monocyte/dendritic cell molecular signature of SARS-CoV-2-related multisystem inflammatory syndrome in children with severe myocarditis.
Med
; 2(9): 1072-1092.e7, 2021 09 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34414385
7.
Common evolutionary features of the envelope glycoprotein of HIV-1 in patients belonging to a transmission chain.
Sci Rep
; 10(1): 16744, 2020 10 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33028961
8.
Potent human broadly neutralizing antibodies to hepatitis B virus from natural controllers.
J Exp Med
; 217(10)2020 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32579155
9.
Phenotypic properties of envelope glycoproteins of transmitted HIV-1 variants from patients belonging to transmission chains.
AIDS
; 32(14): 1917-1926, 2018 09 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29927786
10.
[CRISPR-Cas9 editing of HIV-1 neutralizing human B cells]. / Ingénierie de lymphocytes B humains produisant des anticorps neutralisant le virus VIH-1 par édition génique CRISPR-Cas9.
Med Sci (Paris)
; 35(12): 993-996, 2019 Dec.
Artigo
em Francês
| MEDLINE | ID: mdl-31903905